InvestorsHub Logo
Followers 93
Posts 17830
Boards Moderated 0
Alias Born 11/26/2014

Re: None

Wednesday, 11/30/2016 12:01:03 PM

Wednesday, November 30, 2016 12:01:03 PM

Post# of 32393
Who's Pointing at GNID 11/30/2016.

"Actually he can't point to anything the CEO said that DIDN'T happen, and thats where he loses ALL credibility. Always forward looking doom and gloom. He is the wrong audience for the company to try to prove anything to. The CEO was VERY CLEAR, 2015 was a building year, and 2016 is the year they focus on revenues."
LMAO


Lorraine Maria Yarde $200,000.00+ CEO
Mark Basile $175,000.00+ General Counsel
Glenn McGinnis $150.000,00 VP Product Development
William V. Koch $150,000.00 Chief Sales and Marketing
Faruk Okcetin $125,000.00 President GENE-RX
J. Richard Iler $125,000.00 CFO
Susan K. Kutzner $$$ Shares + Treasurer & Director
NY, MI, NC, CA, OH


GNID filings below as Reference..."for the MINUTIA"
http://www.otcmarkets.com/stock/GNID/filings


Invest in yourself. Control your own Destiny.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.